The North American Hematology Market is estimated to hike at a promising CAGR from 2023 to 2028.
Coagulation analyzers can detect the clotting endpoint in a variety of blood diseases, including hemophilia. In addition, people might be impacted by various blood disorders and cancers.
Y-O-Y rise in the incidence of blood disorders, rapid technological improvements in hematology, and the emergence of high throughput hematology analyzers are majorly accelerating the growth rate of the hematology market in North America.
Growing healthcare capital expenditure installed base of various types of products for North America hematology analyzers and reagents market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on North America hematology analyzers and reagents market. Furthermore, an increase in the adoption rate of automated hematology instruments and a growing preference for high sensitivity point of care (POC) hematology testing would be key drivers impacting the market's overall growth.
However, the hematology market growth in the North American region is expected to be hampered during the forecast period by the high cost of instruments and low adoption of hematology analyzers in emerging markets. The high price of initial setup and rigorous regulations, on the other hand, would function as market barriers, slowing the market's growth rate. In addition, recalls of faulty hematology analyzers and reagents could negatively impact the market's growth.
This research report on the North American hematology market has been segmented and sub-segmented into the following categories:
Geographically, the North American region is currently ruling the global market and is predicted to account for the most significant share during the forecast period. Due to the high prevalence of blood disorders, increased awareness of existing screening procedures for blood-related problems, and increased expenditure on healthcare and wellness, the market in North America is currently the top contributor of revenue to the global market.
In this region, the U.S. accounted for the leading share in 2020. The Canadian hematology market is forecasted to be growing at a promising CAGR during the forecast period.
KEY MARKET PLAYERS:
Companies playing a dominant role in the North America Hematology Market profiled in this report are Siemens AG Healthcare, Johnson & Johnson, Beckman Coulter, Inc., Abbott Laboratories, Thermo Fisher Scientific, Roche, HORIBA Ltd., Sysmex Corporation, Bio-Rad Laboratories Inc., Boule Diagnostics AB, and Mindray Medical International Limited.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com